个人简历

学习经历
博士，美国明尼苏达大学医学院；
博士后，美国耶鲁大学医学院。
工作经历
1999-2005：美国Geron Corp 生物技术公司，资深研究员；
2005-2009:：汕头大学，多学科研究中心，教授，博士生导师，干细胞研究室主任，以引进海外高端人才聘任汕头大学；
2010至今：暨南大学，研究员，博士生导师。以引进海外高端人才聘任暨南大学生命科学技术学院，国家基因工程药物工程研究中心，教育部基因组药物工程研究中心，广东省生物工程药物重点实验室，肿瘤干细胞研究室主任，细胞生物学专业博士招生负责人

研究领域

采用细胞生物学和分子生物学方法开展以下研究:
1.研究治疗各种癌症的抗体药物，用于治疗胃癌，肝癌和肺癌等。
2.研究癌症治疗的调控机制，包括各种信号转导通路和转录因子

近期论文

1.Liu Z, Zhang W, Chen T. Dai L, Lin Z, Zhou X, WEI X*. Selection of fully human nanobodies against cancer stem cell-specific marker EpCAM for cancer therapy. Clinical Cancer Res. Under review. （SCI A1类1区）.
2.Liu X, Chen T, Lin Z, Dai L, Zhou X, WEI X*. Novel Nanobodies Targeting EGFR and their anti-tumor activity in vitro and in vivo. Cancer Res. Under review. （SCI A1类1区）.
3.Liang G, Lin Z, Chen T, Dai L, WEI X*. Isolation of human single-chain variable fragment antibodies against CXCR4 and their anti-tumor activity in vitro and in vivo. Cancer Letters. Under review. （SCI A1类2区）.
4.Zheng DW, Xue YQ, Li Y, Di JM, Qiu JG, Zhang WJ, Jiang QW, Yang Y, Chen Y, Wei MN, Huang JR, Wang K, WEI X*, Shi Z*. Volasertib suppresses the growth of human hepatocellular carcinoma in vitro and in vivo. Am J Cancer Res. 2016;6(11):2476-2488. （SCI A1类2区）.
5.Xue YQ, Cheng KJ, Qiu JG, Mei XL , Zhang WJ, Jiang QW , Qin WM, Yang Y, Zheng DW, Chen Y, Wei MN, WEI X*, Shi Z*. Antioxidant and anticancer activities of raspberry extracts. J Cancer Research Updates, 2015,4:54-59.
6.Xue YQ, Di JM, Luo Y, Cheng KJ, WEI X*, Shi Z*. Resveratrol oligomers for the prevention and treatment of cancers. Oxid Med Cell Longev.2014;2014:765832. （SCI A2类3区）.
7.Xu GZ, Yang L, Zhang WX, WEI X*. All the tested human somatic cells express both Oct4A and its pseudogenes but express Oct4A at much lower levels compared with its pseudogenes and human embryonic stem cells. Stem Cells Dev. 2015;24(13):1546-1557. （SCI A1类2区）.
8.Li P, Zhang J, Liu J, Ma H, Liu J, Lie P, Wang Y, Liu G, Zeng H, Li Z,WEI X*. Promoting the recovery of injured liver with PHBVHHx scaffolds loaded with umbilical cord–derived mesenchymal stem cells. Tissue Eng Part A.2015;21(3-4):603-615. （SCI A1类2区）.
9.Wu Z, Fan L, Xu B, Lin Y, Zhang P, WEI X*. Use of decellularized scaffolds combined with hyaluronic acid and bFGF for skin tissue engineering. Tissue Eng Part A.2015;21(1-2):390-402. （SCI A1类2区）.
10.Wu Z, Tang Y, Fang H，Su Z, Xu B, Lin Y, Zhang P, WEI X*.Decellularized scaffolds containing hyaluronic acid and EGF for promoting the recovery of skin wounds. Journal of Materials Science: Materials in Medicine. 2015,26(1):59. （SCI A1类2区）.
11.Su Z, Li P, Wu B，Ma H, Wang Y, Liu G, Zeng H, Li Z, WEI X*. PHBVHHx scaffolds loaded with umbilical cord-derived mesenchymal stem cells or hepatocyte-like cells differentiated from these cells for liver tissue engineering. Materials Science and Engineering C. 2014, 45:374–382. （SCI A1类2区）.
12.Su Z, Ma H, Wu Z, Wu B, Zeng H, Li Z, Wang Y, Liu G, Xu B, Lin Y, Zhang P, WEI X*, Enhancement of skin wound healing with decellularized scaffolds loaded with hyaluronic acid and epidermal growth factor, Materials Science & Engineering C. 2014, 44: 440–448. （SCI A1类2区）